- Archives
-
-
-
-
-
-
-
-
-
-
-
-
Criteria for contracting HCO
Hans-Dieter Zeitz, Michael Tschöpe and Carlos Fernandez
How the DOE approach can smooth the process
Shamik Pandit
A sponsor's perspective on achieving operational success
Hany Salama, ME
A sponsor's perspective on outsourcing methods
Anthony J. De Stefano, Ph.D.
Exploring the worldwide potential for Biopharma production
Faiz Kermani, Ph.D.
What impact will these growing regions have on Pharma outsourcing?
Enrico Polastro, Ph.D.
Our Editorial Advisory Board answers the question of how you explain U.S. drug pricing to non-Pharma people.
Examining the contract biomanufacturing sector.
A biomanufacturing survey shows the need for production efficiencies.
Our annual survey explores salaries and employment attitudes throughout the industry.
Industry strengthens relationships with sponsors, learns the benefits of flexibility and moves more trials out of the developed world
Sarah W. Madley
Part one of a two-part series on CTM services.
Suggy S. Chrai, Ph.D.
Pharma potential in the far east.
Dr. Faiz Kermani and Dr. Rebecca Gittins
A one-stop reference to the terminology of the pharma and biopharma industry.
Gil Y. Roth
Manage competitiveness through training and staffing
Eric S. Langer
Seizing opportunities the right way
Edward F. Ikeguchi, M.D.
Guidelines for in-house and outsourcing decisions
Joong Hyun
Other players search for their slice of the drug development pie
Steven Heffner
Economic value added as a key tool in API decision making
Cliff R. King, Ph.D.
A look back at 2003 and a look ahead to 2004
Michael A. Martorelli
Benchmarking the best practices of leading manufacturers
Keith Symmers
|
Magazine
